(Q39555908)

13 September 2017

title

Characterization of BCAR4, a novel oncogene causing endocrine resistance in human breast cancer cells (English)

1 reference

antineoplastic resistance

13 September 2017

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21506106

30 November 2024

author name string

Marcia Godinho

1

1 reference

13 September 2017

Danielle Meijer

2

1 reference

13 September 2017

Buddy Setyono-Han

3

1 reference

13 September 2017

Ton van Agthoven

5

1 reference

13 September 2017

Lambert C. J. Dorssers

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21506106

30 November 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21506106

30 November 2024

publication date

1 July 2011

1 reference

13 September 2017

July 2011

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21506106

full work available at URL

30 November 2024

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fjcp.22503

1 reference

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jcp.22503/fullpdf

30 November 2024

1 reference

Journal of Cellular Physiology

30 November 2024

published in

1 reference

13 September 2017

volume

226

1 reference

13 September 2017

issue

7

1 reference

13 September 2017

page(s)

1741-1749

1 reference

Molecular mechanism and clinical implications of endocrine therapy resistance in breast cancer.

13 September 2017

cites work

1 reference

Novel anticancer targets: revisiting ERBB2 and discovering ERBB3.

21 January 2018

1 reference

Prognostic factors in human primary breast cancer: comparison of c-myc and HER2/neu amplification

21 January 2018

1 reference

Oncogene amplification and prognosis in breast cancer: Relationship with systemic treatment

21 January 2018

1 reference

The substrate domain of BCAR1 is essential for anti-estrogen-resistant proliferation of human breast cancer cells

21 January 2018

1 reference

New tools for functional mammalian cancer genetics

21 January 2018

1 reference

Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling.

21 January 2018

1 reference

Identification of a novel breast-cancer-anti-estrogen-resistance (BCAR2) locus by cell-fusion-mediated gene transfer in human breast-cancer cells

21 January 2018

1 reference

Induction of antiestrogen resistance in human breast cancer cells by random insertional mutagenesis using defective retroviruses: identification of bcar-1, a common integration site

21 January 2018

1 reference

Breast cancer oestrogen independence mediated by BCAR1 or BCAR3 genes is transmitted through mechanisms distinct from the oestrogen receptor signalling pathway or the epidermal growth factor receptor signalling pathway

21 January 2018

1 reference

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

21 January 2018

1 reference

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

21 January 2018

1 reference

The maternal legacy to the embryo: cytoplasmic components and their effects on early development

21 January 2018

1 reference

The crystal structure of a truncated ErbB2 ectodomain reveals an active conformation, poised to interact with other ErbB receptors

21 January 2018

1 reference

Relevance of BCAR4 in tamoxifen resistance and tumour aggressiveness of human breast cancer

21 January 2018

1 reference

Safety considerations of adjuvant therapy in early breast cancer in postmenopausal women

21 January 2018

1 reference

c-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes

21 January 2018

1 reference

The ErbB receptors and their role in cancer progression.

21 January 2018

1 reference

Regulation of ERBB2 by oestrogen receptor-PAX2 determines response to tamoxifen

21 January 2018

1 reference

ERBB receptors and cancer: the complexity of targeted inhibitors

21 January 2018

1 reference

First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial

21 January 2018

1 reference

Differential effects of estrogen receptor antagonists on pituitary lactotroph proliferation and prolactin release

21 January 2018

1 reference

The transcriptome of human oocytes

21 January 2018

1 reference

Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line

21 January 2018

1 reference

Resistance to endocrine therapy in breast cancer: exploiting estrogen receptor/growth factor signaling crosstalk

21 January 2018

1 reference

Functional screen for genes responsible for tamoxifen resistance in human breast cancer cells

21 January 2018

1 reference

Profiling gene expression in human placentae of different gestational ages: an OPRU Network and UW SCOR Study

21 January 2018

1 reference

Aromatase inhibitors--gene discovery

21 January 2018

1 reference

Identification of expressed sequence tags preferentially expressed in human placentas by in silico subtraction

21 January 2018

1 reference

Biological determinants of endocrine resistance in breast cancer

21 January 2018

1 reference

Microarray analysis of differentially expressed fetal genes in placental tissue derived from early and late onset severe pre-eclampsia

21 January 2018

1 reference

Pathways to tamoxifen resistance

21 January 2018

1 reference

Oestrogen receptor: a stable phenotype in breast cancer

21 January 2018

1 reference

The maternal-zygotic transition: death and birth of RNAs

21 January 2018

1 reference

How ADAM-9 and ADAM-11 differentially from estrogen receptor predict response to tamoxifen treatment in patients with recurrent breast cancer: a retrospective study

21 January 2018

1 reference

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

21 January 2018

1 reference

New perspectives into the biological and clinical relevance of oestrogen receptors in the human breast

21 January 2018

1 reference

Differential regulation of abundance and deadenylation of maternal transcripts during bovine oocyte maturation in vitro and in vivo.

21 January 2018

1 reference

Induction of estrogen independence of ZR-75-1 human breast cancer cells by epigenetic alterations

21 January 2018

1 reference

Identification of BCAR3 by a random search for genes involved in antiestrogen resistance of human breast cancer cells

21 January 2018

1 reference

Relevance of breast cancer antiestrogen resistance genes in human breast cancer progression and tamoxifen resistance

21 January 2018

1 reference

Functional identification of genes causing estrogen independence of human breast cancer cells

21 January 2018

1 reference

Selective recruitment of breast cancer anti-estrogen resistance genes and relevance for breast cancer progression and tamoxifen therapy response

21 January 2018

1 reference

Italian randomized trial among women with hysterectomy: tamoxifen and hormone-dependent breast cancer in high-risk women

21 January 2018

1 reference

Estrogen-regulated gene expression predicts response to endocrine therapy in patients with ovarian cancer

21 January 2018

1 reference

Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancer

21 January 2018

1 reference

Pathogenesis of preeclampsia

21 January 2018

1 reference

Distinct sets of developmentally regulated genes that are expressed by human oocytes and human embryonic stem cells

21 January 2018

1 reference

Human gene expression first occurs between the four- and eight-cell stages of preimplantation development

21 January 2018

1 reference

Prediction of relapse and survival in breast cancer patients by pS2 protein status

21 January 2018

15

1 reference

Prognostic value of PS2 and cathepsin D in 710 human primary breast tumors: multivariate analysis

30 November 2024

16

1 reference

Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer

30 November 2024

22

1 reference

Distinct gene mutation profiles among luminal-type and basal-type breast cancer cell lines

30 November 2024

24

1 reference

Comparison of estrogen receptor DNA binding in untreated and acquired antiestrogen-resistant human breast tumors

30 November 2024

29

1 reference

Downregulation of erbB3 abrogates erbB2-mediated tamoxifen resistance in breast cancer cells

30 November 2024

32

1 reference

Tamoxifen in the treatment of breast cancer

30 November 2024

41

1 reference

Clinical significance of HER-2/neu oncogene amplification in primary breast cancer. The South Australian Breast Cancer Study Group

30 November 2024

45

1 reference

Ectopic expression of epidermal growth factor receptors induces hormone independence in ZR-75-1 human breast cancer cells

30 November 2024

50

1 reference

The contribution of gene expression profiling to breast cancer classification, prognostication and prediction: a retrospective of the last decade

30 November 2024

58

1 reference

30 November 2024

Identifiers

DOI

10.1002/JCP.22503

1 reference

release_2psmqqb72vdx7pnmp5vjpuffa4

13 September 2017

Fatcat ID

0 references

1 reference